Charles Schwab’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-17,405
Closed -$38.5K 3670
2023
Q2
$38.5K Hold
17,405
﹤0.01% 3457
2023
Q1
$44.2K Hold
17,405
﹤0.01% 3367
2022
Q4
$32.5K Hold
17,405
﹤0.01% 3442
2022
Q3
$45K Hold
17,405
﹤0.01% 3357
2022
Q2
$34K Sell
17,405
-112,267
-87% -$219K ﹤0.01% 3453
2022
Q1
$386K Buy
129,672
+7,019
+6% +$20.9K ﹤0.01% 3154
2021
Q4
$551K Buy
122,653
+6,311
+5% +$28.4K ﹤0.01% 3115
2021
Q3
$566K Sell
116,342
-186,328
-62% -$906K ﹤0.01% 3104
2021
Q2
$2.07M Buy
302,670
+28,130
+10% +$192K ﹤0.01% 2707
2021
Q1
$1.94M Buy
274,540
+3,062
+1% +$21.6K ﹤0.01% 2673
2020
Q4
$1.7M Buy
271,478
+4,146
+2% +$26K ﹤0.01% 2639
2020
Q3
$1.45M Buy
267,332
+5,678
+2% +$30.7K ﹤0.01% 2589
2020
Q2
$1.37M Buy
261,654
+36,057
+16% +$188K ﹤0.01% 2545
2020
Q1
$711K Buy
225,597
+24,569
+12% +$77.4K ﹤0.01% 2591
2019
Q4
$811K Buy
201,028
+8,145
+4% +$32.9K ﹤0.01% 2666
2019
Q3
$834K Buy
192,883
+26,435
+16% +$114K ﹤0.01% 2623
2019
Q2
$665K Buy
166,448
+17,256
+12% +$68.9K ﹤0.01% 2705
2019
Q1
$800K Sell
149,192
-8,343
-5% -$44.7K ﹤0.01% 2617
2018
Q4
$809K Sell
157,535
-1,992
-1% -$10.2K ﹤0.01% 2601
2018
Q3
$1.55M Buy
159,527
+19,397
+14% +$188K ﹤0.01% 2500
2018
Q2
$1.43M Buy
140,130
+11,384
+9% +$116K ﹤0.01% 2474
2018
Q1
$1.67M Buy
128,746
+36,380
+39% +$473K ﹤0.01% 2381
2017
Q4
$1.65M Buy
92,366
+10,202
+12% +$183K ﹤0.01% 2361
2017
Q3
$2.06M Buy
82,164
+45,556
+124% +$1.14M ﹤0.01% 2278
2017
Q2
$883K Buy
36,608
+11,500
+46% +$277K ﹤0.01% 2499
2017
Q1
$484K Hold
25,108
﹤0.01% 2651
2016
Q4
$387K Hold
25,108
﹤0.01% 2748
2016
Q3
$327K Hold
25,108
﹤0.01% 2757
2016
Q2
$350K Buy
25,108
+7,700
+44% +$107K ﹤0.01% 2727
2016
Q1
$265K Hold
17,408
﹤0.01% 2811
2015
Q4
$331K Hold
17,408
﹤0.01% 2824
2015
Q3
$331K Hold
17,408
﹤0.01% 2783
2015
Q2
$449K Buy
+17,408
New +$449K ﹤0.01% 2712